OssDsign AB Logo

OssDsign AB

Developer of orthobiologics for bone regeneration in spinal fusion surgery.

OSSD | ST

Overview

Corporate Details

ISIN(s):
SE0012570448
LEI:
5493005SNS5NAYE2WL53
Country:
Sweden
Address:
Ulls väg 29C, 756 51 Uppsala

Description

OssDsign is a developer and global provider of next-generation orthobiologics products based on advanced material science. The company develops and markets products that support the body's own healing capabilities, with a primary focus on bone regeneration for spinal fusion surgery. Its flagship product, OssDsign Catalyst®, is a nanosynthetic bone graft putty engineered to engage dual bone formation pathways, promoting rapid and reliable bone formation. OssDsign Catalyst® is the first synthetic bone graft to receive clearance for on-label interbody use based on bone graft data alone, allowing it to be used in any interbody cage cleared for use with synthetic bone grafts. This unique regulatory status, combined with its handling characteristics, differentiates the product in the orthobiologics market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OssDsign AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OssDsign AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OssDsign AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Crinetics Pharmaceuticals, Inc. Logo
Develops oral therapeutics for endocrine diseases and endocrine-related tumors.
United States of America
CRNX
Develops drug delivery technology for localized chemotherapy in solid tumors.
Virgin Islands (British)
CRTX
CRISPR Therapeutics AG Logo
A gene-editing company developing gene-based medicines for serious diseases.
United States of America
CRSP
Crossject Logo
Develops emergency medications delivered via a needle-free auto-injector platform.
France
ALCJ
CSL Ltd. Logo
Global biotechnology company developing biotherapies, vaccines, and specialty medicines.
Australia
CSL
CS Medica A/S Logo
Develops and manufactures OTC medical devices and cosmetics containing cannabidiol.
Denmark
CSMED
CTC BIO, INC. Logo
Develops and manufactures human and animal health products using microbial fermentation.
South Korea
060590
Cue Biopharma, Inc. Logo
Develops biologics to selectively modulate the immune system for cancer and autoimmune diseases.
United States of America
CUE
Cullinan Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapies for cancer and autoimmune diseases.
United States of America
CGEM
CUMBERLAND PHARMACEUTICALS INC Logo
Acquires, develops, and commercializes branded drugs for hospital and acute care.
United States of America
CPIX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.